Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

40.00
Delayed Data
As of Dec 13
 +1.85 / +4.85%
Today’s Change
22.25
Today|||52-Week Range
50.05
+58.42%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Schwabe Stefan K F
Executive Vice President-Research & Development
Sale9/07/201795,000$46.58$4.4M-16.32%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale4/24/201754,000$32.37$1.7M+23.46%
Schwabe Stefan K F
Executive Vice President-Research & Development
Buy9/07/201795,000$12.92$1.2M-16.32%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale9/07/201725,000$46.36$1.2M-16.32%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale9/08/201723,481$48.89$1.1M-17.70%
Bhatt Padmanabh P
Sale6/02/201710,000$39.86$398.6K-0.12%
Bhatt Padmanabh P
Sale4/24/201711,806$32.59$384.8K+23.46%
Patrick Gregory S
Chief Financial Officer & Vice President
Buy4/24/201750,000$5.88$294.0K+23.46%
Bhatt Padmanabh P
Sale9/08/20175,000$49.86$249.3K-17.70%
Patrick Gregory S
Chief Financial Officer & Vice President
Buy9/07/201726,519$7.90$209.5K-16.32%
Page of 2